Insights
Publication | Pharmaceutical Compliance Monitor
Recent Trends in Whistleblower Protection under Dodd–Frank
Edward Buthusiem and Gary Miller
October 20, 2014
Edward Buthusiem and Gary Miller discuss how pharmaceutical and medical device manufacturers should stay up to date with Dodd–Frank Act and SEC and DOJ fraud investigations and enforcement actions.